Clinical Trial Update: The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of Noiiglutide Injection for Type 2 diabetes is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Noiiglutide Injection (noiiglutide)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: ACTIVE_NOT_RECRUITING